Skip to main content
Equibles

Prime Capital Investment Advisors, LLC

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 1731446 OVERLAND PARK, KS
Back to INO Full portfolio

Position in INO

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$18,838
-$10,961 QoQ
Shares Held
17,126
0.0% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 101 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in INO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Prime Capital Investment Advisors, LLC holds $15,655,242 across 20 Biotechnology names. INO ranks #19 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 16,572 $10,333,304
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,898 $1,439,523
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 15,336 $1,250,037
4 VKTX
Viking Therapeutics, Inc.
 11,483 $447,951
5 IMTX
Immatics N.V.
 40,000 $405,200
6 MRNA
Moderna, Inc.
 4,985 $349,099
7 IONS
Ionis Pharmaceuticals Inc
 3,938 $312,244
8 RVMD
Revolution Medicines, Inc.
 1,558 $291,782

All Filings in INO

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,838 17,126
2026-03-31 $29,799 17,126
2025-12-31 $31,363 18,025
2025-09-30 $43,180 18,453
2025-06-30 $41,558 20,372
2025-03-31 $49,387 30,299
2024-12-31 $57,260 31,290
2024-06-30 $81,090 10,036
2024-03-31 $141,187 10,172
2023-12-31 $66,826 131,033
2023-09-30 $54,199 138,972
2023-06-30 $19,950 44,335
2023-03-31 $28,537 34,802
2020-03-31 $9,731 1,308